| Quantification of amyloid PET for future clinical use: a state-of-the-art review HG Pemberton, LE Collij, F Heeman, A Bollack, M Shekari, G Salvadó, ... European Journal of Nuclear Medicine and Molecular Imaging 49 (10), 3508-3528, 2022 | 60 | 2022 |
| Longitudinal amyloid and tau PET imaging in Alzheimer's disease: A systematic review of methodologies and factors affecting quantification A Bollack, HG Pemberton, LE Collij, P Markiewicz, DM Cash, G Farrar, ... Alzheimer's & Dementia 19 (11), 5232-5252, 2023 | 5 | 2023 |
| Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies A Bollack, PJ Markiewicz, AM Wink, L Prosser, J Lilja, P Bourgeat, ... NeuroImage 280, 120313, 2023 | 1 | 2023 |
| Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment HG Pemberton, C Buckley, M Battle, A Bollack, V Patel, P Tomova, ... EJNMMI research 13 (1), 48, 2023 | 1 | 2023 |
| Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study A Bollack, LE Collij, DV García, M Shekari, D Altomare, P Payoux, ... Alzheimer's & Dementia 20 (5), 3429-3441, 2024 | | 2024 |
| Methodology dependent sex differences in Aβ‐PET measured with SUVR W Coath, M Modat, MJ Cardoso, PJ Markiewicz, CA Lane, TD Parker, ... Alzheimer's & Dementia 19, e062020, 2023 | | 2023 |
